C. Kelly

发表

Rheumatoid arthritis-related interstitial lung disease: associations, prognostic factors and physiological and radiological characteristics--a large multicentre UK study.

A. Young, C. Kelly, V. Saravanan, 2014, Rheumatology.

Rheumatoid arthritis - treatment 180. Utility of Body Weight Classified Low-Dose Leflunomide in Japanese Rheumatoid Arthritis

Stanley B. Cohen, D. Symmons, M. Dougados, 2011 .

Lung involvement in inflammatory rheumatic diseases.

C. Kelly, K. Iqbal, La'ali Iman-Gutierrez, 2016, Best practice & research. Clinical rheumatology.

Treatment strategies for a rheumatoid arthritis patient with interstitial lung disease

C. Kelly, V. Saravanan, 2008 .

Leflunomide and the lung.

C. Kelly, 2009, Rheumatology.

Major upper airways obstruction associated with Sjögren's syndrome: a case report and literature review.

I. Griffiths, C. Kelly, 1989, British journal of rheumatology.

Current issues in rheumatoid arthritis-associated interstitial lung disease

P. Emery, P. Dieudé, C. Kelly, 2021, The Lancet Rheumatology.

Interstitial lung disease in patients with rheumatoid arthritis: a comparison with cryptogenic fibrosing alveolitis.

B. Rajasekaran, C. Kelly, P. Lord, 2001, Rheumatology.

Acute lower respiratory tract infections in patients with rheumatoid arthritis.

C. Kelly, V. Saravanan, C. Heycock, 2007, The Journal of rheumatology.

Upper limb musculoskeletal abnormalities and poor metabolic control in diabetes.

C. Kelly, V. Saravanan, C. Heycock, 2009, European journal of internal medicine.

FRI0114 Rheumatoid arthritis related interstitial lung disease – relevance of lung function tests and high resolution computed tomography in a large multi centre series

C. Kelly, M. Nisar, S. Arthanari, 2013 .

Pneumococcal antibody levels after pneumovax in patients with rheumatoid arthritis on methotrexate

C. Kelly, V. Saravanan, C. Heycock, 2011, Annals of the rheumatic diseases.

Interstitial lung disease in rheumatoid arthritis: an update on diagnosis and management

C. Kelly, V. Saravanan, S. Malik, 2012 .

Rheumatoid arthritis: classical rheumatoid lung disease.

C. Kelly, 1993, Bailliere's clinical rheumatology.

Rheumatoid arthritis related interstitial lung disease - improving outcomes over 25 years: a large multicentre UK study.

N. Basu, A. Young, C. Kelly, 2020, Rheumatology.

Bronchiectasis Is a Model for Chronic Bacterial Infection Inducing Autoimmunity in Rheumatoid Arthritis

P. Venables, A. Quirke, P. Eggleton, 2015, Arthritis & rheumatology.

Influence of diabetes on peripheral bone mineral density in men: a controlled study

C. Kelly, S. Moochhala, M. Bridges, 2005, Acta Diabetologica.

What effect does Helicobacter pylori infection have on the risk of peptic ulceration in patients receiving NSAIDs for rheumatoid arthritis?

C. Kelly, V. Saravanan, C. Heycock, 2002, European journal of internal medicine.

High resolution computed tomography of the lung in lifelong non-smoking patients with rheumatoid arthritis.

C. Kelly, C. Kelly, N. Keaney, 1995, Annals of the rheumatic diseases.

The glycosylation of haptoglobin in rheumatoid arthritis.

I. Griffiths, C. Kelly, S. Thompson, 1993, Clinica chimica acta; international journal of clinical chemistry.

Exercise testing soon after myocardial infarction: its relation to course and outcome at one year in patients aged less than 55 years.

A. Hall, R. Hall, C. Kelly, 1989, British heart journal.

What's new in … Rheumatology and Autoimmune Diseases

I. Griffiths, C. Kelly, V. Saravanan, 2002 .

How to differentiate between Eosinophilic Granulomatous Polyangiitis and Henoch-Schönlein Purpura

C. Kelly, A. Paul, Dinesh Abhijeeth Shanker, 2022, Mediterranean journal of rheumatology.

Increased disease activity, severity and autoantibody positivity in rheumatoid arthritis patients with co‐existent bronchiectasis

P. Eggleton, C. Kelly, A. De Soyza, 2017, International journal of rheumatic diseases.

Lymphadenopathy in rheumatic patients.

I. Griffiths, C. Kelly, A. Malcolm, 1987, Annals of the rheumatic diseases.

The causes of musculoskeletal chest pain in patients admitted to hospital with suspected myocardial infarction.

C. Kelly, C. Heycock, S. Doe, 2005, European journal of internal medicine.

Cause and Outcome of Atypical Chest Pain in Patients Admitted to Hospital

C. Kelly, L. Spalding, E. Reay, 2003, Journal of the Royal Society of Medicine.

Cause and outcome of atypical chest pain in patients admitted to hospital.

C. Kelly, L. Spalding, E. Reay, 2003, Journal of the Royal Society of Medicine.

Pleuropulmonary abnormalities in primary Sjögren's syndrome.

P. Gardiner, C. Kelly, T. Ashcroft, 1993, The Journal of rheumatology.

Interstitial lung disease in patients with rheumatoid arthritis: comparison with cryptogenic fibrosing alveolitis over 5 years.

C. Kelly, V. Saravanan, P. Lord, 2006, The Journal of rheumatology.

RA autoantibodies as predictors of rheumatoid arthritis in non-cystic fibrosis bronchiectasis patients

P. Eggleton, C. Kelly, A. De Soyza, 2014, European Respiratory Journal.

Sjögren's Syndrome and Other Connective Tissue Disorders [213–222] 213. Sjögren’s Syndrome Activity and Damage Indices Comparison

S. Marie, D. Isenberg, T. Jacques, 2010 .

Bronchial reactivity and airflow obstruction in rheumatoid arthritis.

C. Kelly, N. Keaney, W. Hassan, 1994, Annals of the rheumatic diseases.

A Review of Anorexia Nervosa, Its Relationship to Autism and Borderline Personality Disorder, and Implications for Patient Related Outcomes

C. Kelly, M. Davies, 2019, Journal of Psychiatry and Psychiatric Disorders.

Galectin-9 Is a Possible Promoter of Immunopathology in Rheumatoid Arthritis by Activation of Peptidyl Arginine Deiminase 4 (PAD-4) in Granulocytes

S. Pouwels, P. Eggleton, C. Kelly, 2019, International journal of molecular sciences.

Evaluation of a screening tool for inflammatory joint disease

J. Barbour, C. Kelly, M. Bridges, 2003, Annals of the rheumatic diseases.

Mortality in patients with interstitial lung disease treated with rituximab or TNFi as a first biologic

D. Symmons, K. Hyrich, K. Druce, 2017, RMD Open.

When should we use parenteral methotrexate?

C. Kelly, V. Saravanan, C. Heycock, 2010, Clinical Rheumatology.

Prognostic significance of paraproteinaemia in rheumatoid arthritis.

C. Kelly, H. Foster, I. Griffiths, 1991, Annals of the rheumatic diseases.

The spectrum and burden of in-patient paediatric musculoskeletal diseases in Northern Tanzania

R. Walker, E. McIntosh, C. Kelly, 2022, Paediatrics and international child health.

Lung Disease in Rheumatic Disorders

C. Kelly, 2019, Mediterranean journal of rheumatology.

Nintedanib in Patients With Autoimmune Disease–Related Progressive Fibrosing Interstitial Lung Diseases: Subgroup Analysis of the INBUILD Trial

E. Matteson, M. Aringer, K. Flaherty, 2022, Arthritis & rheumatology.

Ten year follow up of pulmonary function in patients with primary Sjögren's syndrome

I. Griffiths, C. Kelly, B. K. Davidson, 2000, Annals of the rheumatic diseases.

Idiopathic portal hypertension complicating systemic sclerosis: a case report

G. I. Leontiadis, C. Kelly, J. Henry, 2005, BMC gastroenterology.

Pattern and cause of fractures in patients who abuse alcohol: what should we do about it?

C. Kelly, Kieran Kelly, 2013, Postgraduate Medical Journal.

Raynaud's phenomenon affecting the tongue of a patient with scleroderma

C. Kelly, M. Bridges, 2002, Annals of the rheumatic diseases.

Primary Sjögren's syndrome in the North East of England: a long-term follow-up study.

I. Griffiths, C. Kelly, B. K. Davidson, 1999, Rheumatology.

Rheumatoid arthritis: other rheumatoid lung problems.

C. Kelly, 1993, Bailliere's clinical rheumatology.

Chronic pericardial disease in patients with rheumatoid arthritis: a longitudinal study.

I. Griffiths, C. Kelly, A. Malcolm, 1990, The Quarterly journal of medicine.

Sex ratios in HLA related autoimmune disease.

I. Griffiths, C. Kelly, H. Foster, 1991, Annals of the rheumatic diseases.

Evaluation of a dedicated short-stay unit for acute medical admissions.

C. Kelly, Heather Downing, C. Scott, 2008, Clinical medicine.

Primary Sjögren's syndrome in north east England--a longitudinal study.

W. Dick, I. Griffiths, C. Kelly, 1991, British journal of rheumatology.

Lung function in primary Sjögren's syndrome: a cross sectional and longitudinal study.

I. Griffiths, C. Kelly, B. Pal, 1991, Thorax.

Lungfunction in primary Sjdgren ' s syndrome : a cross sectional and longitudinal study Table I Diagnostic criteria usedfor primary

I. Griffiths, C. Kelly, B. Pal, 2022 .

OP0037 Pulsed Cyclophosphamide in the Treatment of Rheumatoid Arthritis-Related Interstitial Lung Disease (RA-ILD)

C. Kelly, M. Nisar, S. Arthanari, 2014 .

Acute and long-term management of patients with vertebral fractures.

R. Francis, C. Kelly, S. Baillie, 2004, QJM : monthly journal of the Association of Physicians.

Identification and treatment of comorbidity in patients with rheumatoid arthritis

C. Kelly, S. Malik, J. Hamilton, 2013 .

Primary sternal osteomyelitis.

C. Kelly, M. Chetty, 1985, Thorax.

Paraproteins in rheumatoid arthritis and related disorders.

C. Kelly, Clive Anthony Kelly, 1992, International journal of clinical & laboratory research.

Rheumatoid arthritis, malignancy, and paraproteins.

C. Kelly, H. Sykes, 1990, Annals of the rheumatic diseases.

Abnormally-fucosylated serum haptoglobins in patients with inflammatory joint disease.

I. Griffiths, C. Kelly, S. Thompson, 1989, Clinica chimica acta; international journal of clinical chemistry.

Thyroid disease and other autoimmune phenomena in a family study of primary Sjögren's syndrome.

P. Charles, I. Griffiths, C. Kelly, 1993, British journal of rheumatology.

Haematuria in rheumatoid arthritis: a follow up study.

I. Griffiths, P. Mooney, C. Kelly, 1988, Annals of the rheumatic diseases.

The lung in ACPA-positive rheumatoid arthritis: an initiating site of injury?

P. Eggleton, C. Kelly, A. De Soyza, 2014, Rheumatology.

Evaluation of a modified early warning system for acute medical admissions and comparison with C-reactive protein/albumin ratio as a predictor of patient outcome.

C. Kelly, J. Hamilton, E. Cairns, 2009, Clinical medicine.

Patient-reported involvement of the eighth cranial nerve in giant cell arteritis

C. Kelly, V. Saravanan, S. Pugmire, 2019, Clinical Rheumatology.

Whipple's disease presenting with lung involvement.

C. Kelly, M. Egan, J. Rawlinson, 1996, Thorax.

Linkage studies of HLA and primary Sjögren's syndrome in multicase families.

I. Griffiths, C. Kelly, H. Foster, 1993, Arthritis and rheumatism.

Increased risk of severe COVID-19 outcomes in patients with rheumatoid arthritis and interstitial lung disease

C. Kelly, 2022, The Lancet Rheumatology.

DQw7 and the C4B null allele in rheumatoid arthritis and Felty's syndrome.

C. Kelly, D. Grennan, P. Sanders, 1990, Annals of the rheumatic diseases.

Hypoadrenalism in patients with fatigue and rheumatic disease

C. Kelly, V. Saravanan, C. Heycock, 2010 .

Assessment of phagocytic function using chemiluminescence.

P. Corris, C. Kelly, H. Hosker, 1989, Blood reviews.

Pancreatic function in patients with primary Sjögren's syndrome.

I. Griffiths, C. Kelly, A. Katrak, 1993, British journal of rheumatology.

rheumatoid arthritis . Bronchial reactivity and airflow obstruction in

C. Kelly, N. Keaney, W. Hassan, 2004 .

Treatment of rheumatoid arthritis-associated interstitial lung disease: a perspective review

C. Kelly, K. Iqbal, 2015, Therapeutic advances in musculoskeletal disease.

Management of osteoporosis in patients with hip fractures.

R. Francis, C. Kelly, S. Baillie, 2000, QJM : monthly journal of the Association of Physicians.

The relationship between rheumatoid arthritis and bronchiectasis.

C. Kelly, P. Gardiner, 1994, Annals of the rheumatic diseases.

Heightened autoantibody immune response to citrullinated calreticulin in bronchiectasis: Implications for rheumatoid arthritis.

W. Ollier, L. Gold, K. Heesom, 2017, The international journal of biochemistry & cell biology.

Levels of CD5+ B cells are not increased in probands or relatives in a family study of primary Sjögren's syndrome.

I. Griffiths, C. Kelly, H. Foster, 1992, Autoimmunity.

C. Kelly, G. Koduri, J. Williamson, 2021, Irish Journal of Medical Science (1971 -).

Tumour necrosis factor inhibitors versus combination intensive therapy with conventional disease modifying anti-rheumatic drugs in established rheumatoid arthritis: TACIT non-inferiority randomised controlled trial

Anita Patel, Vern Farewell, Margaret Heslin, 2015, BMJ : British Medical Journal.

Association of DR3 with susceptibility to and severity of primary Sjögren's syndrome in a family study.

P. Charles, I. Griffiths, C. Kelly, 1992, British journal of rheumatology.

AB1013 Serious effects of alcohol on bone density and fracture incidence

C. Kelly, P. Bartholomew, A. Grapes, 2013 .

101 Safety of Rituximab in Patients with Rheumatoid Arthritis Associated with Bronchiectasis: Results from a Multicentre Cohort

P. Emery, C. Kelly, S. Dass, 2016 .

092 The Effect of Steroids, Azathioprine and Mycophenolate on the Risk of Death in Rheumatoid Lung Disease

A. Young, C. Kelly, F. Woodhead, 2016 .

063 Survival in Rheumatoid Lung Disease is Longer in Patients Treated with Rituximab than in those Receiving Anti-Tumour Necrosis Factor Therapy

A. Young, C. Kelly, F. Woodhead, 2016 .

Effect of rituximab or tumour necrosis factor inhibitors on lung infection and survival in rheumatoid arthritis-associated bronchiectasis.

P. Emery, Md Yuzaiful Md Yusof, E. Vital, 2020, Rheumatology.

Comment on: Patterns of interstitial lung disease and mortality in rheumatoid arthritis.

C. Kelly, K. Iqbal, 2017, Rheumatology.

Natural History, Disease Characteristics and Autoantibody Positivity in Patients with Bronchiectasis and RA: Is the Lung an Initiating Site of Autoimmunity in Rheumatoid Arthritis?

P. Eggleton, C. Kelly, T. Moullaali, 2013 .

Common ground: the overlap between Endocrinology and Rheumatology.

C. Kelly, K. Narayanan, J. Vila, 2009, European journal of internal medicine.

Four-factor risk score for the prediction of interstitial lung disease in rheumatoid arthritis

Jufen Zhang, C. Kelly, G. Koduri, 2023, Rheumatology International.

Is Janus Kinase Inhibition the Future of the Management of Rheumatoid Arthritis-associated Interstitial Lung Disease?

C. Kelly, M. Garton, 2022, US Respiratory & Pulmonary Diseases.

Reply: Adalimumab-associated pulmonary fibrosis

C. Kelly, V. Saravanan, M. Rynne, 2007 .

Fatigue in rheumatoid arthritis.

C. Kelly, Elizabeth J Coulson, Dimitra Methiniti, 2009, Rheumatology.

198. MORTALITY IN PATIENTS WITH RHEUMATOID ARTHRITIS AND INTERSTITIAL LUNG DISEASE TREATED WITH TUMOUR NECROSIS FACTOR INHIBITOR OR RITUXIMAB

D. Symmons, K. Hyrich, K. Druce, 2017 .

The Lung in Rheumatoid Arthritis

C. Kelly, 1999 .

Muscle disorders111. The impact of fatigue in patients with idiopathic inflammatory myopathy: a mixed method study

R. Moots, P. Salkovskis, Yulia Goryachev, 2012 .

The Links Between Fibromyalgia, Hypermobility and Neurodivergence

C. Kelly, V. Saravanan, R. Martín, 2022, Rheumatology.

O36. Rheumatoid-Arthritis-Related Interstitial Lung Disease: Association Between Biologic Therapy and Survival

A. Young, C. Kelly, M. Nisar, 2014 .

Reducing the risk of methotrexate pneumonitis in rheumatoid arthritis.

C. Kelly, V. Saravanan, V. Saravanan, 2003, Rheumatology.